April 23, 2020 / 11:05 PM / a month ago

BRIEF-Emergent Biosolutions Signs Agreement To Be U.S. Manufacturing Partner For J&J's Lead Vaccine Candidate For COVID-19

April 23 (Reuters) - Emergent Biosolutions Inc:

* EMERGENT BIOSOLUTIONS SIGNS AGREEMENT TO BE U.S. MANUFACTURING PARTNER FOR JOHNSON & JOHNSON’S LEAD VACCINE CANDIDATE FOR COVID-19

* AGREEMENT VALUED AT APPROXIMATELY $135 MILLION

* EMERGENT BIOSOLUTIONS - UNDER AGREEMENT, WILL PROVIDE DRUG SUBSTANCE MANUFACTURING SERVICES WITH ITS MOLECULE-TO-MARKET CDMO OFFERING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below